Actus Medical PT receives Investment Bank Analyst Rating Update
Acutus Medical, Inc. (AFIB) reported Q2 EPS of ($0.93), $0.13 worse than the analyst estimate of ($0.80). Revenue for the quarter came in at $4.1 million versus the consensus...
Investing.com – U.S. stocks were lower after the close on Monday, as losses in the Consumer Services, Technology and Basic Materials sectors led shares lower. At the close in...
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company’s product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.